T. Koskinen

413 total citations
9 papers, 302 citations indexed

About

T. Koskinen is a scholar working on Psychiatry and Mental health, Experimental and Cognitive Psychology and Pharmacology. According to data from OpenAlex, T. Koskinen has authored 9 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 5 papers in Experimental and Cognitive Psychology and 4 papers in Pharmacology. Recurrent topics in T. Koskinen's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers), Treatment of Major Depression (4 papers) and Attention Deficit Hyperactivity Disorder (3 papers). T. Koskinen is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers), Treatment of Major Depression (4 papers) and Attention Deficit Hyperactivity Disorder (3 papers). T. Koskinen collaborates with scholars based in Finland, Sweden and Denmark. T. Koskinen's co-authors include Erkka Syvälahti, Björn Appelberg, Timo Muhonen, Hannu Naukkarinen, Leo Niskanen, Maija Valtonen, M. Naarala, Harri Sintonen, Sinikka Sihvo and Juha Auvinen and has published in prestigious journals such as The Journal of Clinical Psychiatry, Acta Psychiatrica Scandinavica and International Clinical Psychopharmacology.

In The Last Decade

T. Koskinen

9 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Koskinen Finland 8 146 141 73 47 34 9 302
Francis Lavergne France 9 153 1.0× 115 0.8× 77 1.1× 52 1.1× 58 1.7× 12 280
Bijan Etemad United States 7 109 0.7× 92 0.7× 104 1.4× 73 1.6× 23 0.7× 10 375
A Khan United States 10 171 1.2× 141 1.0× 131 1.8× 29 0.6× 69 2.0× 23 481
G. A. E. Rudolf Germany 10 126 0.9× 348 2.5× 67 0.9× 35 0.7× 30 0.9× 21 465
John E. Crowder United States 8 184 1.3× 142 1.0× 113 1.5× 22 0.5× 53 1.6× 14 356
J. Andersen Denmark 10 119 0.8× 204 1.4× 84 1.2× 37 0.8× 35 1.0× 16 370
M Ferreri France 10 172 1.2× 249 1.8× 128 1.8× 42 0.9× 36 1.1× 34 430
Héctor A. Ortega-Soto Mexico 8 47 0.3× 88 0.6× 77 1.1× 23 0.5× 44 1.3× 26 312
Joan Buttenfield United States 8 82 0.6× 172 1.2× 77 1.1× 39 0.8× 30 0.9× 10 363
Stephen T.H. Sokolov Canada 11 172 1.2× 149 1.1× 56 0.8× 45 1.0× 50 1.5× 13 370

Countries citing papers authored by T. Koskinen

Since Specialization
Citations

This map shows the geographic impact of T. Koskinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Koskinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Koskinen more than expected).

Fields of papers citing papers by T. Koskinen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Koskinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Koskinen. The network helps show where T. Koskinen may publish in the future.

Co-authorship network of co-authors of T. Koskinen

This figure shows the co-authorship network connecting the top 25 collaborators of T. Koskinen. A scholar is included among the top collaborators of T. Koskinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Koskinen. T. Koskinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Valtonen, Maija, et al.. (2005). Effect of melatonin-rich night-time milk on sleep and activity in elderly institutionalized subjects. Nordic Journal of Psychiatry. 59(3). 217–221. 57 indexed citations
2.
Appelberg, Björn, et al.. (2001). Patients With Severe Depression May Benefit From Buspirone Augmentation of Selective Serotonin Reuptake Inhibitors. The Journal of Clinical Psychiatry. 62(6). 448–452. 113 indexed citations
3.
Lönnqvist, Jouko, Harri Sintonen, Erkka Syvälahti, et al.. (1994). Antidepressant efficacy and quality of life in depression: a double‐blind study with moclobemide and fluoxetine. Acta Psychiatrica Scandinavica. 89(6). 363–369. 64 indexed citations
4.
Rimón, Ranan, et al.. (1993). Moclobemide versus imipramine in depressed out-patients. International Clinical Psychopharmacology. 7(3). 141–148. 13 indexed citations
5.
Wistedt, B., et al.. (1991). Zuclopenthixol decanoate and haloperidol decanoate in chronic schizophrenia: a double‐blind multicentre study. Acta Psychiatrica Scandinavica. 84(1). 14–21. 22 indexed citations
6.
Rimón, Ranan, et al.. (1991). Alprazolam and Oxazepam in the Treatment of Anxious Out-Patients with Depressive Symptoms: A Double-Blind Multicenter Study. Pharmacopsychiatry. 24(3). 81–84. 7 indexed citations
7.
Lepola, Ulla, T. Koskinen, Ranan Rimón, Harri M. Salo, & A. Gordin. (1989). Sulpiride and perphenazine in schizophrenia. Acta Psychiatrica Scandinavica. 80(1). 92–96. 13 indexed citations
8.
Koskinen, T., et al.. (1984). Flupenthixol versus diazepam in the treatment of psychosomatic disorders: a double-blind, multi-centre trial in general practice.. PubMed. 3(9). 573–81. 10 indexed citations
9.
Koskinen, T., et al.. (1975). A STUDY OF ATTEMPTED SUICIDES IN URBAN VERSUS RURAL AREAS, WITH A FOLLOW‐UP. Acta Psychiatrica Scandinavica. 52(4). 283–291. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026